The HKAPI Annual Dinner 2023 on June 7th, held under the theme of Innovate, Integrate & Impact, was the first annual dinner event since 2019 due to the COVID-19 pandemic
HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).
We are delighted to announce that the Annual General Meeting (AGM) of the Hong Kong Association of the Pharmaceutical Industry was held successfully on 22nd March 2023.
The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.
The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.
We are pleased to announce that Mr. Derek Chang has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 9th January 2023.
Asia Summit on Global Health 2022 It is a great privilege for The Hong Kong Association of the Pharmaceutical Industry to join the Asia Summit on Global Health 2022 organized […]
An online EGM was called by the HKAPI Board to pass a resolution to adopt the new Code of Practice.
It was unanimously adopted by members with immediate effect.
HKAPI is pleased to announce that Mr. Howard Lin has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 6th September 2022.
The 1st CEO Meeting of the Term (2022-24) was held online on 11 July 2022. More than 20 CEOs and directors from our member companies joined to meet the new HKAPI Board, and exchanged views on the future directions of the Association.